Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2/27/26 19:48 | 2/26/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Elghandour Rami | CA | DO | SEE REMA | 2 | S.d | -12,619 | 98.42 | 0 | -128 | 693 | D | |||||||||||||||
2/25/26 19:51 | 2/25/26 | ACLX | Health | BioPrd | Biological Products, (No Diag | Gilson Michelle | CA | O | CFO | 6 | S.dm | -4,419 | 81.17 | 0 | -54 | 54 | D | |||||||||||||||
1/20/26 19:59 | 1/20/26 | ACLX | Health | BioPrd | Biological Products, (No Diag | Lubner David Charles | CA | D | 1 | S.d | -450 | 75.00 | 0 | -6 | 22 | D | ||||||||||||||||
1/14/26 19:38 | 9/18/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Heery Christopher | CA | O | CHIEF ME | 8 | S.m | -4,314 | 75.77 | 0 | -57 | 37 | D | |||||||||||||||
6/11/25 17:37 | 4/29/25 | ACLX | Health | BioPrd | Biological Products, (No Diag | Patel Kavita | CA | D | 6 | S.d | -573 | 63.72 | 0 | -9 | -100 | 0 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |